Jaundice affects 60% of all infants worldwide and is characterized by the yellowing of the skin. In the developed world, jaundice is easily diagnosed and treated. However, hospitals in developing countries lack the resources to accurately diagnose jaundice, and untreated jaundice can lead to permanent brain damage.
Our solution, BiliQuant, is a low-cost, point-of-care device that can accurately diagnose jaundice. BiliQuant reads a paper-based strip to measure the concentration of bilirubin, the blood protein that causes jaundice. It then provides the physician with a numerical readout to ensure accurate diagnosis, all for less than 1 cent per test.